A double blinded randomized 2 dose parallel group multi-center clinical trial of HUMAX-CD4 , a fully human monoclonal anti-CD4 antibody in patients with mycosis fungoides (StageIB-IVB) who are refractory or intolerant to Targretin and 1 other standard therapy (PI: Parker, Co-I: Chen) 1% effort 3 subjects